HistoWiz provides automated histopathology for biomedical researchers.
HistoWiz has raised $32.3M in total funding. The most recent round was Series A. The last funding was announced in October 2021.
HistoWiz's investors include Y Combinator, Vivo Capital, ZhenFund, venBio Partners, Asahi Kasei.
HistoWiz is headquartered in Brooklyn, United States.
HistoWiz provides automated histopathology for biomedical researchers.
HistoWiz is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"HistoWiz — Funding & Investors." VCBacked, October 19, 2021, https://www.vcbacked.co/company/histowiz. Accessed August 13, 2026.
VCBacked. (2021). HistoWiz — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/histowiz
{{cite web |title=HistoWiz — Funding & Investors |url=https://www.vcbacked.co/company/histowiz |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated